Delayed embryonic development or a long sperm survival in two mares-A registration conundrum.

Equine Vet J. January 2024;56(1):131 - 136.

Patrick M McCue¹, Philip M Matthews², Melissa J Prell³, Rebecca R Bellone⁴, Heather Allen⁵

¹ Equine Reproduction Laboratory, Colorado State University, Fort Collins, Colorado, USA.; ² Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ³ Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ⁴ Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California, Davis, California, USA.; ⁵ Bureau Veritas Laboratories, Guelph, Ontario, Canada.

Abstract

BACKGROUND:Genetic testing is required for the registration of foals of most equine breeds.

OBJECTIVES:To describe two clinical cases of marked delayed embryonic development or delayed fertilisation in pregnancies generated by embryo transfer.

STUDY DESIGN:Case report.

METHODS:Donor mares were inseminated with semen from one stallion during one oestrous cycle and semen from a different stallion on the subsequent oestrous cycle. Embryo(s) were collected 8 days after ovulation during the second oestrous cycle and transferred into synchronised recipient mares. Genetic testing was performed to determine parentage of the two foals.

RESULTS:For both foals, DNA parentage testing excluded the second stallion as the genetic sire and confirmed that the first stallion, whose semen was inseminated on the previous oestrous cycle, was the actual genetic sire.

MAIN LIMITATIONS:Rare event in horses; two clinical cases are described.

CONCLUSIONS:It is hypothesised that either marked delayed embryonic development or extended sperm survival occurred in the donor mares. Without genetic testing, parentage assignment based solely on breeding records would have been incorrect.

Keywords

DNA; delayed; embryonic development; horse; parentage;

Article Tools:

Medline

Email to me

Archives Highlights:

Case series of maggot debridement therapy demonstrates safety and efficacy for treating problematic wounds in cats and dogs in Mexico.
Treatment was administered by applying 8-10 larvae per square cm surface area directly on the wound bed and covering the wound with a sterile polyester mesh, sutured to the skin. These were left on the wound for cycles of approximately 48 hours (24-72 hours); the cycles were repeated if more than 20% necrotic tissue remained after treatment. Review of these cases revealed that 80% of treated wounds achieved 100% debridement within 48-96 hours of treatment.

National survey reveals elastic price sensitivity for select equine veterinary services.
Willingness-to-pay questions were presented with a payment card approach and addressed 3 common services: annual spring vaccinations, lameness examinations, and emergency colic surgeries. In a payment card approach, respondents choose from among preselected values. Respondents were asked to choose the maximum amount they would be willing to pay for each service.

Effects of intranasal maropitant on clinical signs of naturally acquired upper respiratory disease in shelter cats.
There was no significant difference in clinical improvement score between the maropitant treatment and control groups for conjunctivitis, blepharospasm, ocular discharge, nasal discharge, or total disease severity after 7 days.

Endoparasites of rabbits and hares.
Accurate gross and microscopic identification of endoparasites in rabbits and hares is an important element of the diagnostic work of veterinary anatomic pathologists. Given the zoonotic nature of rabbit and hare endoparasites, such as C. hepatica, E. cuniculi, and others, veterinary pathologists are ideally poised to make valuable contributions to the understanding of the disease ecology of these pathogens in the context of a One Health research program.

Splenic Masses in Dogs: Algorithms for Differentials, Diagnosis, and Definitive Treatment
There is a 63.1% to 70.5% chance a splenic mass is benign if there is no hemoabdomen and a 21.7% to 37.5% chance it is benign if there is hemoabdomen. These numbers replace the two-thirds rule, which said that two-thirds of splenic masses were malignant and two-thirds of malignant masses were HSA, without accounting for hemoabdomen.